About: BIIB033

An Entity of Type: monoclonal antibody, from Named Graph: http://dbpedia.org, within Data Space: dbpedia.org

BIIB033 (also known as Anti-LINGO-1) is a monoclonal antibody targeting LINGO1. As of 2015 it was being developed by Biogen as a treatment for diseases such as multiple sclerosis and optic neuritis.

Property	Value
dbo:abstract	BIIB033 (also known as Anti-LINGO-1) is a monoclonal antibody targeting LINGO1. As of 2015 it was being developed by Biogen as a treatment for diseases such as multiple sclerosis and optic neuritis. (en)
dbo:casNumber	1884474-47-8
dbo:wikiPageID	48208016 (xsd:integer)
dbo:wikiPageLength	2970 (xsd:nonNegativeInteger)
dbo:wikiPageRevisionID	952535671 (xsd:integer)
dbo:wikiPageWikiLink	dbr:Biogen dbr:LINGO1 dbc:Experimental_drugs dbr:Monoclonal_antibody dbr:Multiple_sclerosis dbc:Monoclonal_antibodies dbr:Ocrelizumab dbr:Optic_neuritis
dbp:casNumber	1884474 (xsd:integer)
dbp:legalStatus	Investigational (en)
dbp:synonyms	Anti-LINGO-1 (en)
dbp:type	mab (en)
dbp:wikiPageUsesTemplate	dbt:Infobox_drug dbt:Reflist dbt:Monoclonals_for_immune_system dbt:Monoclonal-antibody-stub
dcterms:subject	dbc:Experimental_drugs dbc:Monoclonal_antibodies
gold:hypernym	dbr:Antibody
rdf:type	owl:Thing dul:ChemicalObject dbo:ChemicalSubstance wikidata:Q8386 dbo:MonoclonalAntibody dbo:Drug
rdfs:comment	BIIB033 (also known as Anti-LINGO-1) is a monoclonal antibody targeting LINGO1. As of 2015 it was being developed by Biogen as a treatment for diseases such as multiple sclerosis and optic neuritis. (en)
rdfs:label	BIIB033 (en)
owl:sameAs	yago-res:BIIB033 wikidata:BIIB033 https://global.dbpedia.org/id/21Gsg
prov:wasDerivedFrom	wikipedia-en:BIIB033?oldid=952535671&ns=0
foaf:isPrimaryTopicOf	wikipedia-en:BIIB033
is dbo:wikiPageRedirects of	dbr:Anti-LINGO-1
is dbo:wikiPageWikiLink of	dbr:LINGO1 dbr:Ocrelizumab dbr:Anti-LINGO-1
is foaf:primaryTopic of	wikipedia-en:BIIB033